To Fight Noncommunicable Diseases, Forge Strong Partnerships

Throughout nearly all of human history, most people died from causes for which pathogens were to blame. But today, noncommunicable diseases (NCDs)—illnesses such as diabetes, heart disease, stroke, cancer, and chronic lung disease—are responsible for more human deaths than all other causes combined. NCDs are also an overlooked cause of poverty, they stifle economic development in countries where they’re common, and their prevalence is increasing globally. According to the World Health Organization, NCDs are now responsible for 68 percent of deaths worldwide, and cumulative economic losses due to NCDs could reach $7 trillion by 2025. Recognizing how essential it is that actors from all sectors and from multiple areas of the health system work together to reverse this trend, Eli Lilly and Company is proud to support the September issue of Health Affairs. The Power Of Partnership As a global biopharmaceutical company, Lilly is committed to finding new answers to the challenges of NCDs, not only through our medicines, but also through innovative partnerships. Through the Lilly NCD Partnership, we are collaborating with leading health organizations in Brazil, India, Mexico, and South Africa to pilot new ways of combating diabetes for people living in low-income communities. Our collective goal is to find sustainable solutions that can be adopted, replicated, and scaled to make life better for more people around the world. For example, as part of the Lilly NCD Partner...
Source: Health Affairs Blog - Category: Health Management Authors: Tags: Costs and Spending Drugs and Medical Technology Equity and Disparities Featured Global Health Health Professionals Long-term Services and Supports Organization and Delivery Population Health Public Health Quality Diabetes Eli Lilly Source Type: blogs